
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The long non‐coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2‐dependent suppression of SOCS3 transcription
Ke‐Jing Zhang, Xiao‐Lang Tan, Lei Guo
Molecular Oncology (2019) Vol. 14, Iss. 2, pp. 309-328
Open Access | Times Cited: 68
Ke‐Jing Zhang, Xiao‐Lang Tan, Lei Guo
Molecular Oncology (2019) Vol. 14, Iss. 2, pp. 309-328
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 192
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 192
Versatile role of curcumin and its derivatives in lung cancer therapy
Milad Ashrafizadeh, Masoud Najafi, Pooyan Makvandi, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9241-9268
Closed Access | Times Cited: 124
Milad Ashrafizadeh, Masoud Najafi, Pooyan Makvandi, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9241-9268
Closed Access | Times Cited: 124
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Gulab Sher, Nadia Aziz Salman, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 152-165
Open Access | Times Cited: 76
Gulab Sher, Nadia Aziz Salman, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 152-165
Open Access | Times Cited: 76
Aldehyde dehydrogenase 1A1 and 1A3 isoforms – mechanism of activation and regulation in cancer
Martina Poturnajova, Zuzana Kozovská, Miroslava Matúšková
Cellular Signalling (2021) Vol. 87, pp. 110120-110120
Open Access | Times Cited: 54
Martina Poturnajova, Zuzana Kozovská, Miroslava Matúšková
Cellular Signalling (2021) Vol. 87, pp. 110120-110120
Open Access | Times Cited: 54
<p>Long Non-Coding Small Nucleolar RNA Host Genes (SNHGs) in Endocrine-Related Cancers</p>
Yuan Qin, Wei Sun, Zhihong Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7699-7717
Open Access | Times Cited: 51
Yuan Qin, Wei Sun, Zhihong Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 7699-7717
Open Access | Times Cited: 51
Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications
Maoye Wang, Jianmei Gu, Xu Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
Maoye Wang, Jianmei Gu, Xu Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
High serum exosomal long non‐coding RNA DANCR expression confers poor prognosis in patients with breast cancer
Wenbiao Shi, Xiaoyan Jin, Yuanfan Wang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 28
Wenbiao Shi, Xiaoyan Jin, Yuanfan Wang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 28
Emerging roles of suppressor of cytokine signaling 3 in human cancers
Lirui Dai, Zian Li, Yiran Tao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112262-112262
Open Access | Times Cited: 36
Lirui Dai, Zian Li, Yiran Tao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112262-112262
Open Access | Times Cited: 36
Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
Calin Nicolescu, Andrew L. Schilb, Jiyoon Kim, et al.
Chemical & Biomedical Imaging (2023) Vol. 1, Iss. 5, pp. 461-470
Open Access | Times Cited: 14
Calin Nicolescu, Andrew L. Schilb, Jiyoon Kim, et al.
Chemical & Biomedical Imaging (2023) Vol. 1, Iss. 5, pp. 461-470
Open Access | Times Cited: 14
<p>LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells</p>
Xian Hu Zhang, Bing Feng Li, Jie Ding, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 4073-4084
Open Access | Times Cited: 36
Xian Hu Zhang, Bing Feng Li, Jie Ding, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 4073-4084
Open Access | Times Cited: 36
LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis
Huijuan Shi, Kejun Li, Jinxin Feng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 35
Huijuan Shi, Kejun Li, Jinxin Feng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 35
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application
Ganesh Kumar Barik, Osheen Sahay, Abhayananda Behera, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188612-188612
Closed Access | Times Cited: 29
Ganesh Kumar Barik, Osheen Sahay, Abhayananda Behera, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188612-188612
Closed Access | Times Cited: 29
Breast Cancer and the Other Non-Coding RNAs
Dana Dvorská, Dušan Braný, Marcela Ňachajová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3280-3280
Open Access | Times Cited: 27
Dana Dvorská, Dušan Braný, Marcela Ňachajová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3280-3280
Open Access | Times Cited: 27
The control of polycomb repressive complexes by long noncoding RNAs
Jackson B. Trotman, Keean C. A. Braceros, Rachel E. Cherney, et al.
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 27
Jackson B. Trotman, Keean C. A. Braceros, Rachel E. Cherney, et al.
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 27
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
Jianwei Feng, Xinyue Meng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Jianwei Feng, Xinyue Meng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
An Imbalance in Histone Modifiers Induces tRNA-Cys-GCA Overexpression and tRF-27 Accumulation by Attenuating Promoter H3K27me3 in Primary Trastuzumab-Resistant Breast Cancer
Ningjun Duan, Yijia Hua, Xueqi Yan, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 4
Ningjun Duan, Yijia Hua, Xueqi Yan, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 4
Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers
Sugela Susana Blancas-Zugarazo, Elizabeth Langley, Alfredo Hidalgo‐Miranda
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Sugela Susana Blancas-Zugarazo, Elizabeth Langley, Alfredo Hidalgo‐Miranda
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The Role of the Fox Gene in Breast Cancer Progression
Shimin Pei, Dechun Zhang, Zhuohan Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1415-1415
Open Access
Shimin Pei, Dechun Zhang, Zhuohan Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1415-1415
Open Access
Heng Xiao, Tong Zhou, Yanfang Yang, et al.
Cancer Science (2025)
Open Access
SNHG family lncRNAs: key players in the breast cancer progression and immune cell’s modulation
Mohamed J. Saadh, Junainah Abd Hamid, H. Malathi, et al.
Experimental Cell Research (2025), pp. 114531-114531
Closed Access
Mohamed J. Saadh, Junainah Abd Hamid, H. Malathi, et al.
Experimental Cell Research (2025), pp. 114531-114531
Closed Access
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential
Yongcheng Su, Qingquan Bai, Wenqing Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 454-454
Open Access
Yongcheng Su, Qingquan Bai, Wenqing Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 454-454
Open Access
Non-Coding RNAs: Overview and Roles in Toxicology
Gail M. Nelson, Tyler L. Bissoondial, Colette N. Miller, et al.
Elsevier eBooks (2025)
Closed Access
Gail M. Nelson, Tyler L. Bissoondial, Colette N. Miller, et al.
Elsevier eBooks (2025)
Closed Access
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
Justin M. Brown, Marie‐Claire D. Wasson, Paola Marcato
Cells (2020) Vol. 9, Iss. 3, pp. 763-763
Open Access | Times Cited: 31
Justin M. Brown, Marie‐Claire D. Wasson, Paola Marcato
Cells (2020) Vol. 9, Iss. 3, pp. 763-763
Open Access | Times Cited: 31
Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
Yan Yao, Xinru Kong, Ruijuan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Yan Yao, Xinru Kong, Ruijuan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17